ACP Video Intervention for Patients With Life-Limiting Illness
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Home ACP Video.
- Who it may be relevant to
- Registry conditions: Health Care Utilization, End Stage Disease. Basic parameters: from 21 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients With Life-Limiting Illness
Overview
The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.
Detailed description
ACP is a process that allows patients to communicate their wishes and preferences or medical care, when they are seriously ill, to their medical providers. The study investigators would like to assess whether a home-ACP video can improve patient-clinician communication about patients wishes for their medical care and lead to more patient-centered care.
This study is a randomized clinical trial of a Home-ACP intervention among 500 adult patients with serious illness receiving medical care at home with the Clover Health House Calls Program. Study participants will be assigned to one of two groups. In one group, participants will continue to receive usual care with their home-based care team. In the second group, participants will continue to receive their usual care with their home-based care team and also view an ACP video that helps them understand ACP and provides education about ACP and hospice care.
Interventions
- Behavioral Home ACP Video
A video focused on Advance Care Planning and Hospice for patients with serious illness
Primary outcome measures
- Hospice utilization [Time frame: up to one year follow-up or death]
Secondary outcome measures (8)
- Hospice length of stay [Time frame: up to one year follow-up or death]
- Rates of documented resuscitation preferences in the Electronic Health Record [Time frame: up to one year follow-up or death]
- Rates of Advance Care Planning documentation in the Electronic Health Record [Time frame: up to one year follow-up or death]
- Patient knowledge about Advance Care Planning [Time frame: Up to two days following the intervention visit]
- Patient reported confidence in care [Time frame: up to two days following the intervention visit]
- Patient reported satisfaction with clinician communication [Time frame: up to two days following the intervention visit]
- Patient reported decisional satisfaction [Time frame: up to two days following the intervention visit]
- Patient reported decisional certainty [Time frame: up to two days following the intervention visit]
Eligibility criteria
Inclusion criteria
- Aged 21 or over
- Have a one-year prognosis or less as determined by Clover Health's validated algorithm
- Speak either English or one of the other 25 languages in which the video intervention is available
Exclusion criteria
- Visually impaired beyond 20/200 corrected
- Acute psychiatric illness or other comorbid condition that impairs cognitive ability to participate in advance care planning discussion as determined by the primary House Call Provider.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Clover Health — Jersey City
Identifiers
NCT: NCT04778761 · 2020P001277